Andexanet Alfa Versus 4F-PCC for Direct Anticoagulation Reversal in Intracranial Hemorrhage: A Quality Improvement (QI) Analysis (P8-7.001)
To compare the effectiveness of andexanet alfa and 4F-PCC in clinical practice at a single institution.
Authors
- Stephan A. Mayer (ORCID: https://orcid.org/0000-0002-1272-6277)
- Hasit Mehta
- Deepika Dilip (ORCID: https://orcid.org/0000-0002-4961-1481)
- Gular Mammadli
- Nimrod Gozum
- William Liu (ORCID: https://orcid.org/0000-0001-8515-5295)
- Audrey Huang (ORCID: https://orcid.org/0009-0000-5214-1321)
- Jenny Yang (ORCID: https://orcid.org/0000-0001-8635-0391)
- Colleen Bond (ORCID: https://orcid.org/0009-0009-5440-5891)
Institutions
- Westchester Medical Center (US)
- New York Medical College (US)
- Neurology, Inc (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208905
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00